| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.26 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.16 | 0.3 |